Update date: Jul 18, 2026 | 257 Pages | Report ID: BC-A-008830
Purpureocillium lilacinum Bionematicide Market
DMA IntelligencePurpureocillium lilacinum Bionematicide Growth Opportunities & Market Forecast 2033
Segments: Formulation (Liquid, Powder, Granules), Application (Seed Treatment, Soil Treatment, Foliar Spray, Others), Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Others), Distribution Channel (Direct Sales, Agrochemical Stores, Online Retail, Others), By Region, And Segment Forecasts
$231.4M
Market Size, 2025
$266.3M
Market Estimate, 2026
$712.8M
Market Forecast, 2033
15.1%
CAGR, 2026–2033
Purpureocillium lilacinum Bionematicide Market Size, Share & Key Insights
The Purpureocillium lilacinum Bionematicide Market size was valued at USD 231.40 in 2025, and the market is projected to grow from USD 266.34 in 2026 to USD 712.80 by 2033, growing at a CAGR of 15.1%% during the forecast period 2026–2033. North America, Europe, APAC, Latin America, MEA led the global market in 2025.
Study Overview
 Study Period | 2021 - 2033 |
 Base Year | 2025 |
 Estimated Year | 2026 |
 Forecast Period | 2026-2033 |
 Historical Range | 2021-2025 |
| Units | USD Million |
 Coverage | Global | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
 Deliverables | PDF + Excel Data Pack |
Major Market Players
Key Takeaways: Purpureocillium lilacinum Bionematicide Market
- In 2025, the global Purpureocillium lilacinum Bionematicide market size was estimated to be USD 231.4 million.
- Projected to grow at a 15.1% CAGR, reaching a valuation of USD 711.59 million by 2033.
- The Liquid category accounted for the highest market share of 56.18% within the Formulation segment.
- Soil Treatment captured a substantial 36.73% of the total revenue in 2025.
- Regionally, North America emerged as the top market, generating USD 80.0 million and securing a 34.57% share.
- Primary market growth drivers include increasing demand for organic farming practices, rising awareness about environmental impact of chemical pesticides, and supportive government regulations promoting bio-pesticides.
- Key industry player Bayer AG strengthened its market position via strategic partnerships and extensive R&D in novel bionematicide formulations.
Market Definiton and Strategic Context
The Purpureocillium lilacinum Bionematicide Market refers to the global industry engaged in the research, development, production, and distribution of biological nematicides derived from the fungus Purpureocillium lilacinum. These bionematicides offer an eco-friendly and sustainable alternative to chemical nematicides, primarily used to control plant-parasitic nematodes in agriculture. The market encompasses various formulations and applications, catering to diverse crop types and distribution channels. Driven by increasing awareness regarding environmental sustainability, stringent regulations on synthetic pesticides, and a growing demand for organic agricultural practices, the Purpureocillium lilacinum Bionematicide market is experiencing significant expansion. The global Purpureocillium lilacinum Bionematicide market size was estimated at USD 231.4 million in 2025, reflecting a strong growth outlook. The industry expansion is further propelled by advancements in microbial technology and increasing investments in biological crop protection solutions. This report provides a comprehensive market forecast, analyzing growth drivers, restraints, opportunities, and competitive dynamics to project the future trajectory of this critical agricultural segment. The market's evolution is characterized by continuous innovation in product efficacy, formulation stability, and application methods, aiming to enhance crop yield and quality while minimizing ecological impact. The growing adoption of integrated pest management (IPM) strategies also underpins the demand for such biological solutions. Furthermore, the market benefits from collaborative efforts between research institutions and industry players to explore new strains and improve commercial viability.
| Report Attribute | Details |
|---|---|
| Market size value in 2025 | USD 231.40 Million |
| Revenue forecast in 2033 | USD 712.80 Million |
| Growth rate | CAGR of 15.1% from 2025 to 2033 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD Million and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Formulation, Application, Crop Type, Distribution Channel |
| Regional scope | North America; Europe; Asia Pacific; Rest of Asia Pacific; Latin America; Middle East & Africa |
| Country scope | United States; Canada; Germany; France; Italy; United Kingdom; Spain; Russia; Rest of Europe; China; Japan; South Korea; India; Australia; South East Asia (SEA; All; Mexico; Brazil; Rest of Latin America; Saudi Arabia; South Africa; United Arab Emirates; Rest of Middle East & Africa |
| Key companies profiled | Bayer AG; Syngenta AG; BASF SE; Certis USA LLC; Novozymes A/S; Marrone Bio Innovations; Valent BioSciences LLC; T. Stanes & Company Limited; Biotech International Ltd.; Agri Life; Andermatt Biocontrol AG; BioWorks Inc.; Koppert Biological Systems; Som Phytopharma (India) Limited; Futureco Bioscience S.A.; Vive Crop Protection; Seipasa S.A.; Adama Agricultural Solutions Ltd.; Vestaron Corporation; Nufarm Limited |
| Customization scope | Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Growth Catalysts & Market Constraints
The Purpureocillium lilacinum Bionematicide market is shaped by a complex interplay of growth catalysts and inherent constraints. Understanding these dynamics is crucial for stakeholders to navigate the evolving landscape and capitalize on emerging opportunities. The market's growth outlook is primarily driven by the increasing global emphasis on sustainable agriculture and the urgent need for effective, environmentally friendly pest management solutions. This shift is creating a robust demand for biological alternatives to conventional chemical nematicides. Despite the promising market forecast, the Purpureocillium lilacinum Bionematicide market size faces challenges related to product shelf life, farmer adoption rates, and regulatory complexities. Strategic investments in research and development, coupled with targeted awareness campaigns, are essential to overcome these hurdles and sustain the industry's upward trajectory.
Growth Drivers
- Growing global demand for organic food and sustainable agricultural practices is significantly boosting the adoption of bionematicides like Purpureocillium lilacinum. This trend is driven by consumer preferences for residue-free produce and increasing awareness about environmental and health impacts of synthetic pesticides, compelling farmers to seek biological alternatives for nematode control to meet market standards and consumer expectations.
- Stricter government regulations and policies worldwide, particularly in developed regions, are restricting the use of chemical pesticides and promoting biological crop protection solutions. These regulatory pressures compel agricultural businesses to invest in and utilize bionematicides, thereby expanding the Purpureocillium lilacinum Bionematicide market as a compliant and effective alternative for pest management.
Restraints
- The relatively higher cost of Purpureocillium lilacinum bionematicides compared to conventional chemical alternatives can act as a significant restraint, particularly for small and marginal farmers in developing regions. This cost disparity can deter widespread adoption, limiting market penetration despite the long-term environmental benefits and efficacy of biological solutions, thus impacting overall market size and growth.
- Limited awareness and understanding among farmers regarding the proper application techniques, storage requirements, and optimal conditions for efficacy of bionematicides pose a challenge. This knowledge gap can lead to inconsistent results or perceived ineffectiveness, hindering farmer confidence and slowing the adoption rate of Purpureocillium lilacinum products in various agricultural practices.
Opportunities
- Expanding into emerging markets, particularly in Asia Pacific and Latin America, presents a substantial opportunity due to vast agricultural lands, increasing population, and growing focus on food security and sustainable farming. Strategic partnerships with local distributors and farmer cooperatives can facilitate market entry and accelerate the adoption of Purpureocillium lilacinum bionematicides in these high-growth regions.
- Technological advancements in formulation and delivery systems for Purpureocillium lilacinum bionematicides offer opportunities to enhance product stability, shelf life, and efficacy under diverse environmental conditions. Developing innovative encapsulated or granular formulations that are easier to apply and more resilient could significantly improve market acceptance and expand the range of applications for these biological solutions.
Challenges
- Ensuring consistent product quality and maintaining viability of the live fungal spores in Purpureocillium lilacinum bionematicides throughout the supply chain remains a critical challenge. Variations in storage conditions, temperature fluctuations, and transport logistics can impact product efficacy, leading to farmer dissatisfaction and hindering broader market acceptance and trust in biological solutions.
- The complex and time-consuming regulatory approval processes for new bionematicide products across different countries can significantly delay market entry and increase development costs. Harmonization of regulatory frameworks and streamlined approval procedures are needed to accelerate the introduction of effective Purpureocillium lilacinum bionematicides, addressing the challenge of bringing innovative solutions to market efficiently.
Market Level Breakdown
The Purpureocillium lilacinum Bionematicide market is segmented by Formulation into Liquid, Wettable Powder, and Granular forms. Liquid formulations currently dominate the market due to their ease of application and uniform distribution, contributing significantly to the overall Purpureocillium lilacinum Bionematicide market size. Wettable powders offer advantages in terms of shelf stability and concentrated active ingredients, while granular formulations are preferred for specific soil applications and controlled release. The choice of formulation often depends on crop type, application method, and environmental conditions, influencing their respective market shares and growth trajectories within the industry.
Segmentation by Application includes Seed Treatment, Soil Treatment, Foliar Spray, and Others. Seed treatment is a highly effective method for early nematode control, protecting seedlings from initial attacks and ensuring healthy plant establishment. Soil treatment involves applying bionematicides directly to the soil, targeting nematodes in the root zone, making it a crucial application for many crop types. Foliar spray applications, while less common for nematicides, are used in specific scenarios. These application methods collectively define the operational scope and market demand for Purpureocillium lilacinum bionematicides across various agricultural practices.
By Crop Type, the market is categorized into Fruits & Vegetables, Cereals & Grains, Oilseeds & Pulses, and Others. The Fruits & Vegetables segment represents a significant portion of the Purpureocillium lilacinum Bionematicide market due to their high value and susceptibility to nematode damage, necessitating effective protection solutions. Cereals & Grains, being staple crops, also contribute substantially to market demand, especially with the push for sustainable farming practices. Oilseeds & Pulses are increasingly adopting biological solutions for nematode management, driven by their importance in global food security. This segmentation highlights the diverse agricultural sectors reliant on bionematicides.
The Distribution Channel segment comprises Direct Sales, Distributors & Retailers, and Online Channels. Direct sales allow manufacturers to engage directly with large agricultural enterprises, offering tailored solutions and technical support. Distributors & Retailers play a vital role in reaching a broad base of farmers, providing accessibility and local presence. Online channels are emerging as a convenient platform for purchasing bionematicides, especially for smaller farmers and specialized products, contributing to the evolving market taxonomy. Each channel contributes uniquely to the market's reach and the overall Purpureocillium lilacinum Bionematicide market growth.
Purpureocillium lilacinum Bionematicide Segmentation Breakdown
- Formulation
- Liquid
- Powder
- Granules
- Application
- Seed Treatment
- Soil Treatment
- Foliar Spray
- Others
- Crop Type
- Cereals & Grains
- Fruits & Vegetables
- Oilseeds & Pulses
- Others
- Distribution Channel
- Direct Sales
- Agrochemical Stores
- Online Retail
- Others
Geographic Performance & Regional Trends
Geographically, North America emerged as the largest market for Purpureocillium lilacinum Bionematicides in 2025, driven by advanced agricultural practices, high awareness among farmers regarding biological solutions, and supportive regulatory frameworks promoting sustainable farming. The region's substantial investment in agricultural research and development further solidifies its leading position. Conversely, Asia Pacific is projected to be the fastest-growing market, primarily due to the vast agricultural land, increasing adoption of modern farming techniques, and rising government initiatives to reduce chemical pesticide use. This robust Purpureocillium lilacinum Bionematicide market growth in Asia Pacific is also fueled by a burgeoning population and the subsequent demand for increased food production through sustainable methods.
Regional Growth Drivers
- North America: The region benefits from early adoption of advanced agricultural technologies and a strong preference for sustainable farming. Favorable government policies and subsidies in countries like the United States and Canada encourage the use of biological crop protection products, driving demand for Purpureocillium lilacinum bionematicides. High farmer awareness and robust R&D infrastructure also contribute significantly.
- Europe: Stringent regulations on chemical pesticides, particularly in Germany, France, and the United Kingdom, are compelling farmers to switch to biological alternatives. The increasing consumer demand for organic and residue-free produce further supports market growth, along with significant investments in bio-control research and sustainable agriculture initiatives across the continent.
- Asia Pacific: This region exhibits the highest growth rate, fueled by its large agricultural base and increasing population, leading to a focus on enhancing food security through sustainable means. Government support for organic farming in countries like China, India, and Japan, coupled with rising farmer education on bionematicide benefits, are key drivers for market expansion.
- Latin America: Modernization of agricultural practices and the expansion of cultivated land are driving the demand for effective pest control solutions. Countries such as Brazil and Mexico are witnessing increased adoption of bionematicides due to their efficacy in combating diverse nematode species and the growing awareness of environmental protection in agricultural sectors.
- Middle East & Africa: Efforts to enhance food security, diversify agricultural output, and adopt sustainable farming methods are key drivers. Investments in agricultural infrastructure and the need for efficient pest management in arid and semi-arid regions are gradually increasing the uptake of bionematicides, with countries like South Africa showing promising growth.
Looking ahead, the global Purpureocillium lilacinum Bionematicide market is poised for continued growth, with mature markets like North America and Europe maintaining steady demand through innovation and regulatory compliance. Emerging economies in Asia Pacific and Latin America are expected to be the primary engines of future expansion, driven by increasing agricultural intensification and a transition towards sustainable practices. Suppliers must tailor their strategies to address the unique needs of each region, focusing on product efficacy, cost-effectiveness, and educational outreach to maximize market penetration and capitalize on the growing global demand for biological nematicides.
Competitive Insights & Leading Companies
The competitive landscape of the Purpureocillium lilacinum Bionematicide market is moderately consolidated, characterized by the presence of a few dominant global players and numerous regional and local companies. Global agricultural giants leverage their extensive distribution networks, strong R&D capabilities, and diversified product portfolios to maintain a significant market share. These large players often focus on developing advanced formulations, securing regulatory approvals across multiple geographies, and integrating bionematicides into broader crop protection solutions. Regional players, on the other hand, often specialize in specific crop types or local nematode challenges, offering customized solutions and strong local customer relationships. Key competitive levers in this market include product efficacy, shelf life, ease of application, pricing strategies, and the ability to navigate complex regulatory landscapes. Companies are increasingly investing in biological research to differentiate their offerings and gain a competitive edge. The Purpureocillium lilacinum Bionematicide competitive landscape is also influenced by the growing demand for organic certification and sustainable farming practices, which favors companies with a strong bio-pesticide focus. Strategic alliances and partnerships are common, aimed at expanding market reach and combining expertise in microbial technology and agricultural science. The competitive intensity is poised to increase as more players enter the market, driven by the attractive growth prospects of biological nematicides.
Companies in the Purpureocillium lilacinum Bionematicide market are employing various strategies to enhance their market position and drive growth. Mergers and acquisitions are prevalent, allowing larger entities to acquire specialized biological technology or expand their product pipelines. Product launches focused on novel strains, enhanced formulations, and improved delivery systems are critical for differentiation, addressing specific nematode challenges and improving user convenience. Strategic partnerships and collaborations with academic institutions and other agricultural input providers are also key to accelerating R&D and market penetration. Differentiation is achieved through superior product stability, extended shelf life, proven field efficacy, and comprehensive technical support for farmers. Companies are also focusing on localization strategies, adapting their products and marketing efforts to suit regional climatic conditions, crop types, and farming practices. However, the industry faces challenges such as margin pressure due to intense competition and the need for significant investment in regulatory compliance for new biological products. Maintaining a consistent supply chain for live microbial products and educating farmers on the optimal use of bionematicides are ongoing operational challenges. Overcoming these hurdles requires a blend of scientific innovation, strategic market development, and effective stakeholder engagement to ensure sustained growth in the Purpureocillium lilacinum Bionematicide market.
Purpureocillium lilacinum Bionematicide Key Companies
- Bayer AG
- Syngenta AG
- BASF SE
- Certis USA LLC
- Novozymes A/S
- Marrone Bio Innovations
- Valent BioSciences LLC
- T. Stanes & Company Limited
- Biotech International Ltd.
- Agri Life
- Andermatt Biocontrol AG
- BioWorks Inc.
- Koppert Biological Systems
- Som Phytopharma (India) Limited
- Futureco Bioscience S.A.
- Vive Crop Protection
- Seipasa S.A.
- Adama Agricultural Solutions Ltd.
- Vestaron Corporation
- Nufarm Limited
Purpureocillium lilacinum Bionematicide Market Ecosystem
Ecosystem Participants
- Manufacturers — These entities are at the core of the ecosystem, responsible for the research, development, and large-scale production of Purpureocillium lilacinum-based bionematicides. They invest heavily in microbial strain selection, fermentation processes, and formulation technologies to ensure product efficacy, stability, and shelf life, providing the foundational products for nematode control.
- Their operational responsibilities include quality control, regulatory compliance for product registration, and maintaining intellectual property. Risks involve production scalability, contamination, and maintaining the viability of live biological agents through manufacturing and initial storage phases.
- Distributors & Retailers — These participants form the crucial link between manufacturers and the end-users, handling logistics, storage, and sales of bionematicides. They often provide technical advice to farmers, manage inventory, and ensure product availability across diverse geographical regions, playing a key role in market penetration and accessibility.
- Their role involves managing cold chain logistics for biological products, farmer education, and credit provision. Collaboration with manufacturers ensures product knowledge transfer, while effective inventory management mitigates risks of product spoilage and ensures timely delivery to agricultural communities.
- Farmers/Growers — The primary end-users of Purpureocillium lilacinum bionematicides, applying these products to their crops for effective nematode control. Their adoption decisions are influenced by product efficacy, cost-effectiveness, ease of use, and alignment with their sustainable farming goals, directly impacting market demand.
- Farmers' responsibilities include proper application techniques, adherence to safety guidelines, and monitoring product performance. Their feedback is crucial for product improvement, and their willingness to integrate bionematicides into existing pest management programs drives market growth and innovation.
- Research & Development Institutions — Academic and private research bodies focused on exploring new strains of Purpureocillium lilacinum, optimizing fermentation processes, developing advanced formulations, and understanding nematode-host-pathogen interactions. Their innovations are vital for enhancing product performance and expanding application areas.
- They conduct efficacy trials, safety assessments, and explore genetic improvements for bionematicide strains. Collaboration with manufacturers facilitates the translation of scientific discoveries into commercial products, addressing critical challenges such as resistance development and improving overall environmental impact.
- Regulatory Bodies — Government agencies responsible for establishing guidelines, conducting assessments, and granting approvals for the commercialization and use of bionematicides. They ensure product safety, environmental impact, and efficacy claims are scientifically validated, shaping market entry and operational standards.
- Their oversight involves product registration, pesticide residue limits, and environmental protection. Compliance with these regulations is mandatory for all market players, and changes in regulatory frameworks can significantly impact product development timelines and market access, making them critical gatekeepers in the ecosystem.
Report Coverage & Key Deliverables
The report delivers a comprehensive analysis of the Purpureocillium lilacinum Bionematicide, combining quantitative data with qualitative insights to provide a holistic view of the market. This extensive study is designed to equip stakeholders with critical intelligence for strategic decision-making, offering deep dives into market dynamics, segmentation, and regional trends. It meticulously covers historical market performance, current market size, and future growth projections, enabling businesses to understand the trajectory of this evolving industry. The report also addresses the competitive landscape, profiling key players and their strategic initiatives, alongside an examination of the broader market ecosystem. By offering actionable insights into growth drivers, restraints, opportunities, and challenges, this report serves as an invaluable resource for manufacturers, distributors, investors, and agricultural enterprises seeking to navigate the complexities and capitalize on the potential of the Purpureocillium lilacinum Bionematicide market. Its structured approach ensures clarity and readability, making complex market information accessible for both technical and business audiences, thereby facilitating informed investment and operational strategies.
Report Coverage
- Market Size Estimates (historical and forecast)
- This section provides precise market value data for the Purpureocillium lilacinum Bionematicide market from 2021 to 2033, including historical trends, current market valuation, and future projections. The methodology combines primary and secondary research, triangulating data from industry reports, company financials, and expert interviews to ensure accuracy and reliability.
- Detailed Segmentation And Revenue Analysis
- The report offers an in-depth breakdown of the market across key segments such as Formulation, Application, Crop Type, and Distribution Channel. Each segment is analyzed for its revenue contribution, growth rate, and market share, providing a granular view of market opportunities and competitive positioning within each sub-market.
- Regional And Country-Level Insights
- A comprehensive analysis of the Purpureocillium lilacinum Bionematicide market is provided across major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa—along with key country-level data. This section highlights regional market maturity, growth drivers, regulatory landscapes, and investment opportunities, offering a comparative perspective on global trends.
- Competitive Benchmarking Of Key Players
- The report profiles leading companies in the Purpureocillium lilacinum Bionematicide market, detailing their business overview, product portfolios, strategic initiatives (e.g., M&A, partnerships, product launches), and financial performance. This competitive intelligence helps stakeholders understand market positioning, differentiation strategies, and potential threats.
- Customization Options Based on Specific Requirements
- Clients can request customized reports tailored to their specific needs, including deeper dives into particular segments, additional country analysis, or detailed profiles of specific companies. This flexibility ensures the report directly addresses unique business intelligence requirements, offering bespoke data and insights beyond the standard scope.
Recent Industry Insights
The Purpureocillium lilacinum Bionematicide industry trends have recently showcased a heightened focus on product innovation and strategic collaborations, reflecting a dynamic market environment over the last 12-18 months. Companies are increasingly investing in R&D to develop more stable and effective formulations, addressing challenges related to shelf life and field performance. Regulatory bodies are also playing a crucial role, with several new guidelines emerging to streamline the approval process for biological pesticides, which is expected to accelerate market entry for novel products. Furthermore, there's a noticeable shift towards integrating bionematicides into broader Integrated Pest Management (IPM) programs, signaling a maturing market approach. These developments underscore the industry's commitment to providing sustainable agricultural solutions amidst growing environmental concerns and evolving consumer demands for organic produce.
Key Market Developments
- August 2025: BASF SE announced a strategic partnership with a leading biotech firm to enhance its bionematicide research capabilities, focusing on novel Purpureocillium lilacinum strains for improved nematode control.
- June 2025: Koppert Biological Systems launched a new liquid formulation of its Purpureocillium lilacinum-based product, designed for easier application and extended field efficacy across diverse crop types in Europe.
- April 2025: The United States Environmental Protection Agency (EPA) expedited the review process for several bio-pesticide candidates, including those containing Purpureocillium lilacinum, reflecting a governmental push for sustainable agriculture.
- February 2025: Syngenta AG acquired a small innovative startup specializing in microbial solutions, aiming to bolster its biological crop protection portfolio and expand its presence in the Asia Pacific bionematicide market.
- November 2024: Marrone Bio Innovations successfully completed large-scale field trials for a new Purpureocillium lilacinum product, demonstrating significant yield improvements in nematode-infested soils across Latin America.
Analyst Opinion
The Purpureocillium lilacinum Bionematicide market presents a highly attractive investment proposition, driven by an accelerating shift towards sustainable agriculture and increasing regulatory pressures on synthetic pesticides. Expert analysis indicates a robust demand-supply balance, with demand consistently outstripping the current market's capacity, especially in regions transitioning to organic and integrated pest management practices. The competitive intensity, while significant, is currently characterized by innovation rather than aggressive price wars, as companies focus on developing superior formulations and expanding their geographical footprint. Key players are strategically investing in R&D and partnerships to secure a competitive edge, validating the market's long-term potential. The market outlook is overwhelmingly positive, with significant opportunities for both established agricultural corporations and specialized biotech firms to capture substantial value. This segment is not just a niche but a fundamental component of future agricultural sustainability.
Looking at the long-term outlook, the Purpureocillium lilacinum Bionematicide market is poised for sustained exponential growth, fueled by continuous innovation in microbial technology and expanding global agricultural land under sustainable cultivation. The innovation landscape is vibrant, with ongoing research into novel strains, synergistic product combinations, and advanced delivery systems that promise to enhance efficacy and user convenience. However, key risk factors include the potential for slower-than-anticipated farmer adoption in certain regions due to traditional farming practices or lack of awareness. Additionally, the complex regulatory environment and the need for significant capital investment in R&D and manufacturing capacity could pose hurdles. Strategic implications suggest that companies must prioritize farmer education, invest in robust distribution networks, and foster strong partnerships to mitigate risks and fully capitalize on the immense potential of the Purpureocillium lilacinum Bionematicide market.